Meet the expert

Strategies for Early Market Access Planning

July 25, 2024 | 1:00pm - 2:00pm EDT

As market access challenges grow, pharma companies are beginning their pre-launch planning much earlier in the product lifecycle. According to our research, 33% of pharma companies are now starting their market access planning in Phase I, and 54% by Phase II and III.


What can pharma companies hope to learn about the competitive landscape so far in advance? This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.

You will learn:

  • How historic analogs can help your team decide whether to pursue or license a product
  • When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition
  • What kind of data helps you anticipate (and circumvent) launch disadvantages

Register Today

Team #4
Meet our very talented experts

Catherine Humphries

Senior Consultant for MMIT’s Advisory Services

Catherine Humphries is a senior consultant for MMIT’s Advisory Services who helps pharmaceutical and biotech companies solve payer access and managed care challenges. For more than a decade, Cathy has focused on providing recommendations to oncology manufacturers. Her expertise spans many therapeutic areas, including auto-immune diseases, transplantation, cardiology, and vaccines. She holds a Bachelor of Science degree from the University of North Texas.


Benjamin Hinton II, PharmD

Senior Market Access Solutions Analyst

Benjamin Hinton II, PharmD is a senior market access solutions analyst at MMIT. He helps pharmaceutical clients identify potential gaps and competitive intelligence opportunities, using his commercial and patient-centric experience to provide a strategic market access point of view. Ben has more than nine years of experience in the industry, including several years as a staff pharmacist at CVS. Ben is a registered pharmacist who holds a Doctor of Pharmacy degree from Hampton University.